Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-202472
Filing Date
2017-06-13
Accepted
2017-06-13 16:23:01
Documents
85
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d382568d10ka.htm 10-K/A 450706
2 EX-10.40 d382568dex1040.htm EX-10.40 94181
3 EX-23.2 d382568dex232.htm EX-23.2 1555
4 EX-31.1 d382568dex311.htm EX-31.1 9428
5 EX-31.2 d382568dex312.htm EX-31.2 9396
6 EX-32.3 d382568dex323.htm EX-32.3 3394
7 EX-32.4 d382568dex324.htm EX-32.4 3368
14 GRAPHIC g382568g18h18.jpg GRAPHIC 3109
  Complete submission text file 0001193125-17-202472.txt   4776383

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ceru-20161231.xml EX-101.INS 775272
9 XBRL TAXONOMY EXTENSION SCHEMA ceru-20161231.xsd EX-101.SCH 63848
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20161231_cal.xml EX-101.CAL 72349
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20161231_def.xml EX-101.DEF 250209
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20161231_lab.xml EX-101.LAB 535118
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20161231_pre.xml EX-101.PRE 404634
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36395 | Film No.: 17909119
SIC: 2834 Pharmaceutical Preparations